I already did the math and because of that I bought 2K. Big gains coming.
these shorts are unreal.
buy it up.
firemen were already there when video was taken, Do the DD.
Seeking Alpha Market Currents
October 7, 2013
Jefferies stays bullish on Tesla Motors
Jefferies ups its price target on Tesla Motors (TSLA +3%) to $210
Leader in Moile Advetiding Will be Alot Higher Than $ 50's
Facebook: Artificial Intelligence Project Is A Game Changer
Sep 30 2013
Facebook has successfully made the move to mobile and mobile is where everything is converging. By successfully implementing AI software to help disseminate the tremendous amount of data that is and will be able to be mined, Facebook is positioning itself to be the undisputed leader in Mobile advertising.
With the future potential that Facebook is looking to bring to market these prices look like a bargain
Investing Ideas |
Dividends & Income |
Macro View |
Home » Become a Seeking Alpha Contributor
Become a Seeking Alpha Contributor
We're thrilled you're considering becoming a contributor! Here are some of the benefits of submitting articles to Seeking Alpha, the #1 website for sophisticated analysis of U.S. stock markets:
Contributors' article links are emailed to Seeking Alpha alert subscribers. More than 500,000 users receive alerts, which are sent every time a single-stock article is published.
Article links are also emailed to SA newsletter subscribers in digest format. We have 846,198 email subscribers.
Article links are syndicated all over the web. Your article headline will appear on Yahoo Finance, MSN Money, CNBC, MarketWatch, Bloomberg terminals, and many more places.
Average page-views per Premium article: 5,042
Cash & Benefits
Premium articles (articles that are exclusive to Seeking Alpha, more here) earn $10/thousand page-views (CPM).
Premium articles may also be selected by editors for SA Pro, our subscription-based research platform for professional investors. Pro articles receive a guaranteed minimum payment of $100-500. SA Pro contributors also receive free access to SA Pro for each article selected (see more details about SA Pro here).
There are two steps to becoming a contributor on Seeking Alpha:
Step 1: Register as a contributor
Once you're signed in on the website, click here to fill out your contributor details.
You will be prompted for your real name and contact details; this information will be kept private, and will not be shared on the Seeking Alpha website.
When you’ve finished filling out the requested information, click on "Register as a contributor." Congratulations, you're now registered as a Seeking Alpha contributor.
Step 2: Submit an article
Once you finish registering as a contributor, you will automatically be directed to the Submit an Article page where you can decide what kind of article you'd like to submit.
If you choose to write a Premium article, you will then be asked to submit your payment details so that Seeking Alpha can pay you for the Premium articles you have published.
This author gets it :
These 4 Companies Are Creating the Next Generation of Cancer Treatments
By Leo Sun
Celldex has two major products, which could soon put it on the map: rindopepimut, a treatment for a rare type of brain cancer (gliboblastoma), and CDX-011, an ADC for metastatic breast cancer built on technology licensed from Seattle Genetics.
Celldex reported positive results from its phase 2 study of rindopepimut, which prolonged the patients' average survival rate by 24.6 months, compared to the median survival rate of 15 months. Based on the rarity of gliboblastoma, rindopepimut has been classified as an orphan drug by both the FDA and the European Medicines Agency.
Celldex also finished a phase 2b trial of CDX-011 with positive results, reporting a 32% overall response rate in patients compared to a 13% rate in those administered the placebo.
Considering these two positive factors, analysts at Leerink Swann raised their target price on the stock to $ 45.
will be great ride